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P2X receptors are cation channels gated by extracellular
ATP. The widespread expression of these receptors in both
neuronal and non-neuronal tissue suggests that P2X
receptors are likely to play a role in a variety of processes such
as pain sensation, auditory transduction and cardiovascular
regulation (Brake & Julius, 1996; Ralevic & Burnstock, 1998;
Housley, 2000; Burnstock, 2001; Khakh, 2001). Two
endogenous modulators that differentially affect the seven
P2X receptor subtypes that have been cloned from rat are
extracellular pH and zinc (Brake & Julius, 1996; Ralevic &
Burnstock, 1998: Khakh, 2001). Proton and zinc modulation
have both been suggested to occur by allosteric regulation of
the P2X receptors rather than by an effect on ATP, because
changes in the species of ATP present do not correlate with
changes in receptor properties (King et al. 1996; Li et al. 1996;
Stoop et al. 1997). 
Acidic extracellular pH (e.g. pH 6.5) potentiates P2X2 and
P2X2/3 receptor currents and decreases the EC50 of the ATP
concentration–response relation (King et al. 1996, 1997;
Nakazawa et al. 1997; Stoop et al. 1997; Wildman et al. 1997,
1998); however, the same pH change inhibits the responses
of P2X1, P2X3 and P2X4 receptors (Stoop et al. 1997;
Wildman et al. 1999a, b). The pH sensitivity of P2X receptors
is within the range of pH values seen under physiological
conditions (e.g. inflammation, seizures, hypoxia), which
suggests that pH modulation of P2X receptors has a
significant role in vivo (Chesler, 1990; Reeh & Steen, 1996).
For example, pH modulation of P2X receptors may allow
respiratory neurons to detect changes in blood CO2 levels via
changes in blood pH (Thomas & Spyer, 2000).
Extracellular zinc (< 100 m) potentiates the responses of
homomeric P2X2, P2X3 and P2X4 receptors as well as those of
heteromeric P2X2/6 and P2X4/6 receptors, but inhibits the
responses of P2X1 and P2X7 receptors (Nakazawa et al. 1997;
Nakazawa & Ohno, 1997; Le et al. 1998; Wildman et al. 1998,
1999a, b; King et al. 2000). The physiological significance of
zinc modulation of P2X receptors is unclear, but the co-
localization of P2X receptors and zinc in the nervous system
(e.g. in the hippocampus and cerebral cortex) suggests that
this modulator may play an important role in vivo (Smart
et al. 1994; Kanjhan et al. 1999).
The pH–response relation for P2X2 has a pKa reported to
be between 7.0 and 7.9 (King et al. 1997; Stoop et al. 1997;
Ding & Sachs, 1999). The amino acid with a pKa closest to
this range is histidine. The pKa of free histidine is 6.0
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(Tanokura, 1983), but in proteins the pKa of histidines can
range from 5.0 to 8.0 (Kao et al. 2000), making histidines
obvious candidates for the proton-binding site involved in
pH potentiation. However, diethylpyrocarbonate (DEPC), a
compound that covalently modifies histidines and makes
them unable to be protonated, has no effect on pH
modulation of P2X2 (Stoop et al. 1997; Wildman et al. 1998)
or P2X4 (Clarke et al. 2000) receptors, suggesting that
histidines are not involved in pH potentiation. An
alternative explanation for these results is that DEPC did
not gain access to some essential histidine in P2X2, and this
explanation gained support when it was reported that a
histidine in P2X4 receptors is necessary for proton
inhibition of P2X4 receptor currents (Clarke et al. 2000).
Histidine residues may also be involved in zinc binding to
P2X2 receptors. Histidines are prominent in the zinc-
binding domains of many enzymes (Christianson, 1991),
and histidines are essential for the zinc sensitivity of GABA
(Wang et al. 1995; Wooltorton et al. 1997), NMDA (Choi
& Lipton, 1999; Paoletti, 2000) and glycine (Harvey et al.
1999) receptors. 
To test whether histidines are involved in modulation of
P2X2 receptors by extracellular protons and zinc, we singly
substituted alanines for each of the nine histidines in the
extracellular domain of the rat P2X2 receptor. Our results
demonstrate that mutating one histidine (H319) greatly
reduced pH potentiation with no effect on zinc modulation.
In contrast, mutating either one of two histidines (H120




Rat P2X2 cDNA in pcDNA1 was obtained from Dr D. Julius,
University of California, San Francisco, CA, USA (Brake et al.
1994). Mutagenic oligonucleotides were obtained from Operon
Technologies, Inc. (Alameda, CA, USA), and contained the base
changes necessary for a single amino acid substitution and for the
introduction or deletion of a restriction enzyme recognition site.
Most mutant P2X2 receptors were made using the QuickChange
Site-Directed Mutagenesis kit (Stratagene, LaJolla, CA, USA). For
some mutations, we used overlap extension by polymerase chain
reaction (Ho et al. 1989; Vallejo et al. 1995). Putative mutants were
first screened by restriction enzyme digestion and then confirmed
by DNA sequencing (University of Michigan DNA Sequencing
Core, Ann Arbor, MI, USA). Each mutant is referred to by the
original amino acid (one letter code) followed by the residue
number and the substituted amino acid (one letter code). The
oligonucleotide sequences and the diagnostic restriction sites
introduced or deleted were:
H120A: 5‚-GAGCATGAGGGTTGCTAGCTCTACCTGCCA-3‚
(adds Nhe I);
H125A: 5‚-AGCTCTACCTGCGCTTCAGACG-3‚ (adds Hha I);
H146A: 5‚-AAGGCAATGGGATCCGGACAGGGGCCTGT-











H319A: 5‚-GTTATCGTGGCGGGACAGGCAG-3‚ (adds Bsm FI);
H319K: 5‚-TGTTATCGTGAAGGGACAGGCAGGGAAATT-3‚
(adds BsmFI).
Expression of P2X2 receptors 
P2X2 receptors were expressed in defolliculated stage V–VI Xenopus
laevis oocytes. Oocytes were harvested by procedures approved by
the University of Michigan Committee on the Use and Care of
Vertebrate Animals, and have been described in detail elsewhere
(Zhou & Hume, 1998). Frogs were anaesthetized by immersion in
well water containing 3-aminobenzoic acid ethyl ester (1 g l_1,
Sigma) and were humanely killed after the final collection of
oocytes.
P2X2 and mutant receptor RNA were synthesized using the T7
mRNA Message Machine kit from Ambion (Austin, TX, USA)
and quantified both spectroscopically and on ethidium bromide
gels. Fifty nanolitres of RNA (typically 2–5 ng ml_1) were injected
into each oocyte. Two-electrode voltage clamp experiments were
carried out 1–5 days after RNA injection. To compare the
maximum responses of the different constructs, we injected 50 nl
of a high concentration of RNA (100 ng ml_1) to saturate translation,
thereby eliminating variation due to differences in the quality of
the RNA. In the data reported in Table 1, all oocytes came from a
single frog, and were studied after 2 days. 
Solutions
The base oocyte recording solution (ORS) contained (m):
90 NaCl, 1 KCl, 1.32 MgCl2, 10 Hepes, pH 7.5. We compensated
for the chelation of Mg2+ by ATP by adding MgCl2 to the solutions
used such that all solutions contained 1 m free Mg2+, as
determined by the program Bound and Determined (Brooks &
Storey, 1992). The ATP stock solution consisted of disodium
adenosine 5‚-triphosphate (ATP; Sigma-Aldrich, St Louis, MO,
USA) dissolved at 100 m in double-distilled H2O; aliquots were
stored at _20 °C for 1–3 months. The ATP concentrations of all
solutions were verified by taking spectroscopic measurements at
259 nm. A 1  stock of ZnCl2 was dissolved in acidic double-
distilled H2O in order to prevent precipitation. 
For recording, ATP stock solutions were diluted in ORS with the
required zinc and magnesium, followed by adjustment of the pH
to the required level. All solutions were used within 48 h.
Electrophysiological recordings and data analysis
P2X2 and mutant receptor currents were investigated using two-
electrode voltage clamp (in most experiments an npi TurboTec 3
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apparatus was used; in the remainder an Axon Instruments
Geneclamp 500B apparatus was used). All experiments were done
at room temperature (22 oC), and unless otherwise stated the
holding potential was _50 mV. The rate of P2X2 receptor current
desensitization is slow, concentration dependent and varies between
batches of oocytes (Zhou et al. 1998). More importantly, once
fully desensitized, P2X2 receptors recover very slowly (Zhou et al.
1998). Thus, obtaining a concentration–response relation for P2X2
receptors by sequentially applying higher concentrations of ATP
to the same oocytes is likely to cause significant desensitization.
Therefore, the final concentration–response relation will be that
for a mixture of desensitized and non-desensitized P2X2
receptors, which will result in an underestimation of the EC50,
because desensitized receptors have a higher affinity for ATP. To
obtain the most accurate estimate of the concentration–response
relations (reported in Table 1), our strategy was to expose each
oocyte to only two concentrations of ATP: a small non-
desensitizing concentration of ATP (10 m) immediately followed
by a test concentration of ATP (5–200 m). The ratio between
these current amplitudes was then averaged among five to seven
oocytes for each test concentration of ATP (30–50 total oocytes
per construct). The plot of these averaged ratios was fitted using
the Hill equation, and re-normalized to a maximum of 100 %. The
EC50 obtained for wild-type P2X2 receptors using this method
(30 m; Table 1) was 136 % of that obtained by estimating the
EC50 with sequential 20 s applications of ATP to single oocytes
(22 m; Figs 3C, 5D and 8A). Since average concentration–response
relations of individual oocytes were not obtained using this
protocol, we report the standard error of the regression from
Sigma Plot 5.0 as a measure of the precision of the fit. In other
experiments, we used an ascending series of ATP concentrations
on single oocytes to measure changes in the maximum response of
a cell with pH or zinc.
Data are expressed as means ± ... unless otherwise specified.
Box plots of potentiation ratios (Figs 2 and 7) display the median
values and the 10 %, 25 %, 75 % and 90 % percentiles because the
data were not normally distributed.
RESULTS
Effect of histidine mutations on the ATP
concentration–response relation
To test whether any of the nine histidine mutations altered
ATP responsiveness, we measured the ATP concentration-
response relations of the mutants expressed in Xenopus
oocytes, as described in Methods. The histidine mutations
only slightly altered the EC50 of the receptor to ATP (Table
1). The most left-shifted mutant was H319A and the most
right-shifted mutant was H146A, but these changes in the
EC50 were less than 2-fold different from wild-type P2X2.
To test whether the maximum response of these mutants
was altered we injected oocytes with a high concentration
of RNA (5 ng oocyte_1) to saturate translation and assayed
oocytes after similar incubation times. The maximum
responses of eight histidine mutants were not different
from wild-type; however, the maximum response of H319A
was reduced 6-fold compared with wild-type (Table 1). 
H319A altered the pH sensitivity of P2X2 receptor
currents
As an initial screen to identify mutants that altered the
sensitivity of P2X2 receptors to pH, we tested whether the
responses of mutant receptors to 10 m ATP were
potentiated when the extracellular pH was dropped from 7.5
to 6.5 (Figs 1 and 2). The potentiation ratios for individual
oocytes expressing wild-type P2X2 receptors varied from 4-
to 16-fold. The source of this variation is not yet clear, but the
potentiation ratios for eight of the nine histidine mutants
also fell within this range (median potentiation ratios
varying from 4- to 10-fold). In contrast, the responses to
10 m ATP of individual oocytes expressing H319A were
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Table 1. Parameters of the ATP concentration–response relations for wild-type and mutant
P2X2 receptors
Hill Maximum
EC50 (m) coefficient current (mA)
P2X2 30.1 ± 2.5 1.96 ± 0.23 25.2 ± 2.7 
H120A 39.2 ± 0.8 2.00 ± 0.05 18.3 ± 0.8 
H125A 26.9 ± 5.9 2.80 ± 1.25 21.1 ± 1.1 
H146A 40.1 ± 11.8 1.33 ± 0.31 22.3 ± 2.1 
H152A 22.2 ± 1.1 2.31 ± 0.22 21.0 ± 1.0 
H174A 26.2 ± 2.3 1.73 ± 0.19 22.1 ± 1.4 
H192A 23.2 ± 3.6 2.35 ± 0.70 17.7 ± 1.8 
H213A 35.3 ± 0.1 2.65 ± 0.02 18.9 ± 1.6
H245A 22.0 ± 4.1 2.74 ± 1.22 25.9 ± 1.7
H319A 16.1 ± 2.5 2.02 ± 0.54 4.1 ± 0.3
The half-maximal effective concentrations (EC50) and Hill coefficients of wild-type and mutant receptors in
response to ATP (5–500 m) were determined as described in Methods using 5–7 oocytes per concentration
of ATP for each construct (30–50 total oocytes per construct). To compare the maximum response of these
receptors to ATP, oocytes from a single batch were injected with a large amount of RNA (5 ng oocyte_1).
After incubation for 2 days, the current amplitudes in response to 1 m ATP of 7–10 oocytes per construct
were measured. All oocytes were held at _50 mV. 
never potentiated by more than 1.9-fold (median
potentiation ratio = 1.37, n = 14). 
The failure of H319A to potentiate in response to acidic
pH might result from several different mechanisms. The
simplest case would be if the H319A mutant was
insensitive to protons. However, Fig. 3 demonstrates that
the actual situation was more complex. The potentiation
of wild-type P2X2 by pH is characterized by a substantial
decrease in the EC50, with little change in the maximum
current (King et al. 1996, 1997; Nakazawa et al. 1997; Stoop
et al. 1997). This is most readily demonstrated by applying
an ascending series of concentrations of ATP (Fig. 3A and
B) to the same oocyte at two different pH values. Although
this procedure produced a slight underestimation of the
actual EC50 (see Methods), it had the advantage that the
amplitudes of the maximal responses could be more easily
compared under the two conditions. For each oocyte, we
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Figure 1. Potentiation of wild-type and mutant receptor currents by pH
Each trace is the response of a single oocyte expressing wild-type or mutant receptors to 10 m ATP at pH 7.5
and pH 6.5. The bars above each trace indicate the duration of the applications. The time scale applies to all
traces.
Figure 2. Potentiation of currents by protons was
greatly diminished for H319A
The pH potentiation ratio is the ratio of the current amplitude
in the presence of 10 m ATP at pH 6.5 to the response at
pH 7.5. Lines within the boxes indicate the median potentiation
ratio (n = 7–27 oocytes for each mutant construct,
n = 52 oocytes for wild-type). The upper and lower boundaries
of each box plot demarcate the 75th and 25th percentiles,
respectively. The horizontal lines above and below each box
indicate the 90th and 10th percentiles. The dashed line indicates
a ratio of 1 (no potentiation).
determined the ATP concentration–response relation at
pH 7.5, waited 5 min to allow for recovery from
desensitization, and then determined the ATP
concentration–response relation at either pH 6.5 or 7.5
(control). The similarity of the initial and control
concentration–response relations at pH 7.5 (Fig. 3B)
indicated that relatively little long-term desensitization
occurred under the conditions used. Reducing the pH
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Figure 3. The ATP concentration–response relations for wild-type and H319A change with
pH
A and D, representative current responses of single oocytes expressing P2X2 (A) or H319A (D) to increasing
concentrations of ATP at pH 7.5 and then at pH 6.5 after allowing a 5 min recovery between traces. The
numbers and the filled and open bars above the graphs indicate the concentration and duration of ATP
application. B and E, the ATP concentration–response relations for P2X2 (B) and H319A (E) were derived
from experiments like those shown in A and D. All currents were normalized to the maximum current
amplitude of the initial concentration response at pH 7.5. The concentration–response relations at pH 7.5
following a 5 min incubation (pH 7.5 control) were similar to the initial concentration–response relations at
pH 7.5. C and F, sample traces of the responses of oocytes expressing wild-type (C) or H319A (F) receptors to
either 5 or 100 m ATP at pH 7.5 (open bars) and pH 6.5 (filled bars). The time scales in C and F apply to both
traces. The arrows in D and F indicate a transient increase in the current response of H319A after switching
from a high concentration of ATP at pH 6.5 back to the recording solution without ATP at pH 7.5. For some
points the error bars (...) were smaller than the symbols.
from 7.5 to 6.5 decreased the EC50 of wild-type P2X2 by
about 4-fold (from 22.5 ± 0.7 to 5.1 ± 0.2 m, n = 7; Fig. 3B)
and the pH potentiation ratios predicted from the curves
in Fig. 3B matched very well with the actual pH
potentiation ratios obtained. The curves shown in Fig. 3B
predict pH potentiation ratios of 14.1 and 1.18 at 5 and
100 m ATP, respectively. When individual oocytes were
‘jumped’ directly from pH 7.5 to 6.5 at these ATP
concentrations, the median ratios were 16.8 (n = 8) and
1.23 (n = 8), respectively (Fig. 3C). 
Like wild-type P2X2, the concentration–response relation
of H319A showed a leftward shift in the EC50 from
12.4 ± 0.6 to 4.9 ± 0.1 m (n = 7; Fig. 3D and E). However,
this did not produce very much potentiation, because the
maximal response to ATP was decreased about 2-fold at
pH 6.5. As a consequence, decreasing the pH from 7.5 to
6.5 potentiated the response of H319A to 5 m ATP by
only 2.37 ± 0.20-fold (n = 14) and inhibited the response
to 100 m ATP (potentiation ratio of 0.71 ± 0.02, n = 8;
Fig. 3F). Interestingly, changing from solutions with a high
concentration of ATP (100 or 200 m ATP) at pH 6.5 to
the bath recording solution at pH 7.5 produced a transient
increase in the current (after-spike) before the current
returned to baseline (arrows in Fig. 3D and F). 
We investigated the sensitivity of the H319A mutant to pH
by examining relative current amplitudes across a range of
pH values. Since pH has different effects at different
concentrations of ATP, we studied the pH–response
relations of H319A and P2X2 at a low and a high
concentration of ATP: 5 and 100 m (Fig. 4A and B). At 5 m
ATP, the pH–response relation of H319A (pKa = 7.71 ±
0.11, n = 6) was shifted compared with that of wild-type
P2X2 (pKa = 6.83 ± 0.003, n = 5). At 100 m ATP, H319A
receptor currents decreased with decreasing pH
(pKa = 5.98 ± 0.12, n = 5) with no indication of potentiation
at any pH tested (Fig. 4B). In contrast, for 100 m ATP the
relation between P2X2 receptor currents and pH was bell-
shaped with a maximum response at pH 7.0. This bell-
shaped relation results from the combined potentiating and
inhibiting effects of pH. We used the inhibitory
pH–response relation of H319A to scale P2X2 currents ratios
at 100 µ ATP and calculated the pKa of the potentiating
effect to be 7.60 ± 0.21 (n = 5). 
To explore further the mechanism of action of the H319A
mutation, we compared the effect of zinc and pH
potentiation on oocytes expressing P2X2 or H319A
(Fig. 5A). For wild-type P2X2, the maximal potentiation
that could be achieved by optimal levels of zinc or protons
was similar. With 5 m ATP at pH 7.5, the average
potentiation to 20 m zinc was 14.9 ± 4.5-fold, and the
average potentiation in pH 6.5 solution was 12.6 ± 3.6-
fold (n = 5). For a series of five cells, the average ratio of
zinc potentiation to pH potentiation was 1.14 ± 0.04. A
second important feature of the responses of wild-type
P2X2 was that the amplitude of the maximally potentiated
current was similar to the current that was elicited by a
high concentration of ATP (200 m) at pH 7.5 with no
zinc (see Figs 3C and 8A). Finally, the two types of
potentiation were not independent. At pH 6.5, a level that
caused nearly maximal pH potentiation of the response of
P2X2 to 5 m ATP but relatively little inhibition (see Fig. 4A),
very little additional potentiation was produced by adding
20 µ zinc (1.22 ± 0.04-fold, n = 5). Thus the potentiation
caused by these two modulators occlude each other. When
zinc and pH potentiation was compared in H319A-
expressing oocytes the results were quite different
(Fig. 5B). For 5 µ ATP, the potentiation of H319A by
20 µ zinc at pH 7.5 was 15.1 ± 1.6-fold, nearly identical
to the zinc potentiation of P2X2. However, as noted above,
the maximal potentiation that could be achieved at pH 6.5
was much smaller (2.34-fold) and for a series of five cells,
the average ratio of zinc potentiation to pH potentiation
was 5.06 ± 0.38. Furthermore, pH potentiation did not
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Figure 4. The relation between pH and current responses
of P2X2 and H319A receptors at 5 mM ATP (A) and 100 mM
ATP (B) 
The symbol legend in  A also applies to  B. All currents were
normalized so that the maximum ratio of the fit was 100 %. The
curves shown for responses to 5 m ATP and for H319A at 100 m
ATP were fitted to the data using the Hill equation. To fit the data
for potentiation of wild-type P2X2 at 100 m ATP, we scaled the
data using the inhibitory pH–response relation of H319A at
100 m. The fit of this adjusted pH response of P2X2 receptor
currents is shown as a dashed line in B.
effectively occlude the response of H319A to zinc. At pH 6.5,
addition of 20 µ zinc caused the response to 5 µ ATP to
increase 4.22 ± 0.22-fold (n = 5). Thus the mechanism
that produces the residual pH potentiation in H319A is
much less efficacious than the mechanisms that produce zinc
potentiation in H319A and pH potentiation in P2X2.
One additional property that was altered in the H319A
mutation was the desensitization evident with high agonist
concentration (see for example Figs 1, 3 and 6). The rate
and magnitude of desensitization of P2X2 varies widely
between oocytes studied under identical conditions (Zhou
et al. 1998), but a substantial number of the P2X2-expressing
oocytes we studied showed detectable desensitization
(time constant of 7–60 s) and in these oocytes the current
at steady state declined to less than 80 % of the initial
current. In contrast, the observed desensitization of H319A
to high agonist concentration was uniformly slow (time
constant of > 60 s) and the steady state currents were
typically 90–100 % of peak currents.
A final set of experiments concerning the mechanism of
pH potentiation examined the properties of the H319K
mutation. The rationale for these experiments was that if
H319 is the proton sensor responsible for normal pH
potentiation, then a positive charge at this position should
mimic protonation of this histidine, and produce a left-
ward shift of the concentration–response curve at pH 7.5.
Indeed, there was a leftward shift of over 40-fold. The
mean EC50 obtained from applying gradually increasing
concentrations of ATP (Fig. 5C) was 0.63 ± 0.23 µ,
compared with 29.1 ± 5.9 µ for oocytes from the same frog
injected with RNA encoding P2X2 (Fig. 5D). As was the
case for the H319A mutation, when the ATP concentration
was low relative to the EC50, there was a residual pH-
dependent potentiation of the H319K currents. When
0.2 µ ATP was used (a concentration that produced
nearly the same fractional response as 5 µ ATP did on
H319A), the pKa for the potentiation was 7.6 ± 0.3 (n = 5),
and the potentiation was nearly maximal at pH 7.0. Like
the pH potentiation in H319A, the residual potentiation
was not very efficacious. The current achieved with 0.2 µ
ATP at pH 7.0 (maximal pH potentiation) was much
smaller (28 %) than the current that could be elicited by
increasing ATP to 5 µ at pH 7.5. Finally, as was the case
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Figure 5. Additional characterization of mutations at H319 
A and B, comparison of the effect of zinc and pH on single oocytes expressing P2X2 (A) or H319A (B). For
P2X2 the potentiation elicited by switching from 5 µ ATP at pH 7.5 to either 5 µ ATP plus 20 µ zinc at
pH 7.5 or to 5 µ ATP alone at pH 6.5 was very similar, but for H319A the potentiation elicited by switching
to acidic pH was much smaller than the potentiation that could be elicited by zinc. In addition, potentiation
by 20 µ zinc was mostly occluded by pH 6.5 potentiation in P2X2 but not in H319A. C, currents elicited
from an oocyte expressing H319K in response to step concentration increases in ATP at pH 7.5.
D, concentration–response relations of a series of oocytes from a single frog expressing P2X2, H319A or
H319K. Each graph is the average for 5–6 oocytes studied as in C. For some points the error bars (...) were
smaller than the symbols. 
with P2X2 and H319A, an inhibitory action of protons
became apparent at quite acidic pH. For H319K studied
with 0.2 µ ATP, the inhibition was sufficiently powerful
that by pH 6.5 it dominated over the potentiation so that
the ratio of current at pH 6.5 to the current at pH 7.5 was
0.59 ± 0.2 (n = 3). 
In summary, these data clearly demonstrate that H319
plays an important role in pH potentiation but not zinc
potentiation. Whether the properties of the H319A and
H319K mutations are consistent with H319 serving as the
primary sensor for the pH modulation observed in P2X2 is
explored in the Dicussion.
Two histidine mutations reduced zinc potentiation
of P2X2 receptor currents
We next tested whether any of the nine histidine mutations
reduced the ability of zinc to modulate P2X2 receptor
currents (Figs 6 and 7). The response of P2X2 receptors to
10 µ ATP was potentiated ~8-fold in the presence of
20 µ zinc. Strikingly, zinc had little or no effect on the
responses of two histidine mutant receptors (H120A and
H213A). The remaining seven histidine mutant receptor
currents exhibited zinc potentiation similar to wild-type.
Zinc potentiation of P2X2 receptor currents results from a
decrease in the EC50 of the ATP concentration–response
relation with little change in the maximum response
(Wildman et al. 1998; Xiong et al. 1999), similar to the effect
of low pH described above. We therefore tested whether zinc
alters the ATP concentration–response relations of either
H120A or H213A (Fig. 8). These experiments were
performed on single oocytes in order to also compare the
maximum response of these receptors with and without
zinc. We first applied ascending concentrations of ATP in the
absence of zinc. Then, after a 5 min recovery period, we
applied another ascending series of ATP concentrations
either with 20 µ zinc or without (control). As was shown
above, the initial and control ATP concentration–response
relations were not significantly different from each other. For
P2X2, the EC50 was decreased 4-fold from 21.34 ± 0.54 µ
(n = 11) in the absence of zinc to 5.11 ± 0.78 µ (n = 6) in
the presence of 20 µ zinc. In contrast, the ATP
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Figure 6. Potentiation of wild-type and mutant receptors by zinc
Each trace is the response of a single oocyte expressing wild-type or mutant receptor to 10 µ ATP followed
by 10 µ ATP with 20 µ zinc. The bars above each trace indicate the duration of the applications. The time
scale applies to all traces.
concentration–response relations of H120A and H213A
were not significantly altered by 20 µ zinc.
To further characterize the zinc sensitivity of H120A and
H213A, we determined the concentration–response
relations for zinc (Fig. 9). Both H120A and H213A currents
were inhibited by zinc with IC50 values of 112 ± 13 and
110 ± 24 µ and Hill coefficients of 1.50 ± 0.25 and
1.26 ± 0.33, respectively. The zinc concentration–response
relation for P2X2 was bell-shaped, reflecting the combined
effects of zinc potentiation and inhibition. We used the
inhibitory zinc–response relations of H120A and H213A
to scale P2X2 currents ratios and calculated that the zinc
concentration–response relation for potentiation at 10 µ
ATP had an EC50 of 16.5 ± 4.5 µ and a Hill coefficient of
0.92 ± 0.16. 
The reduced potentiation of H120A and H213A receptor
currents by zinc allowed us to investigate the nature of the
inhibitory zinc binding site. Inhibition of P2X2 receptor
currents by high concentrations of zinc may be due to
either an allosteric modification or to a block of the
channel pore, similar to the effect of magnesium on
NMDA receptors. If zinc inhibits current responses by
blocking the channel pore and the zinc binding site lies
within the membrane field, this inhibition should be
voltage dependent. However, Fig. 10 shows that this
inhibitory effect was not voltage dependent. In summary,
H120 and H213 are required for zinc potentiation but are
not necessary for voltage-independent, low-affinity zinc
inhibition.
DISCUSSION
In this study, we used site-directed mutagenesis to test
whether any of the nine histidines in the extracellular
domain of P2X2 receptors are necessary for zinc or proton
potentiation. One histidine mutation (H319A) dramatically
reduced pH potentiation of receptor currents with no effect
on zinc potentiation; two mutations (H120A, H213A)
eliminated zinc potentiation with no effect on pH
potentiation. The ability to eliminate one type of
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Figure 7. Zinc potentiation was greatly reduced in two
histidine mutants, H120A and H213A 
The zinc potentiation ratio is the ratio of the current amplitude in
the presence of 10 µ ATP and 20 µ zinc to the current
amplitude in response to 10 µ ATP alone. Lines within the boxes
indicate the median potentiation ratio (n = 15–25 oocytes per
mutant construct, 55 oocytes for wild-type). The upper and lower
boundaries of each box demarcate the 75th and 25th percentiles,
respectively. The horizontal lines above and below each box
indicate the 90th and 10th percentiles. The dashed line indicates a
ratio of 1 (no potentiation).
Figure 8. ATP concentration–response relations for P2X2
(A), H120A (B) and H213A (C ) with and without 20 mM
zinc 
After obtaining a concentration–response relation in the absence
of zinc (1, No Zinc), 5 min was allowed for recovery and then a
second concentration–response relation was obtained in either the
absence (9, No Zinc Control) or presence of 20 µ zinc (0). All
currents were normalized to the maximum current amplitude of
the initial concentration–response relation in the absence of zinc.
potentiation with no effect on the other suggests that zinc
and protons act to potentiate the receptor at independent
sites. 
Inhibition by high concentrations of zinc and protons
Zinc potentiation of P2X2 responses to 10 µ ATP
attenuates at zinc concentrations greater than 100 µ.
Similarly, pH potentiation of P2X2 responses to 100 µ
ATP peaks at pH 7 and then falls with lower pH. Thus, zinc
and pH potentiation in wild-type P2X2 receptors mask
inhibitory effects of zinc and protons. By eliminating zinc
potentiation, H120A and H213A mutants revealed this
inhibitory effect of zinc even at low concentrations of zinc.
Likewise, the basic shift in the pKa of the pH potentiation
caused by mutating H319 revealed an inhibitory effect of
protons at pH 6.5, a pH value that greatly potentiates wild-
type P2X2 receptor currents. Since zinc inhibition was
maintained in H120A and H213A, and proton inhibition
in H319A, these results suggest that the lower affinity
inhibitory sites for protons and zinc are independent of the
higher affinity potentiating sites for these modulators. At
present we do not know what residues might be required
for this inhibition. However, a promising approach to
identifying such residues is to make double mutants
(H319A plus another residue or H120A plus another
residue) to probe pH or zinc inhibition, respectively. 
The inhibitory effect of protons on the maximum response
of H319A receptors can explain why H319A currents
induced by high concentrations of ATP at pH 6.5 briefly
increased (after-spike) before returning to baseline when
the solution was changed to zero ATP at pH 7.5. This is
expected to occur if the rate of deprotonation of the
inhibitory site is faster than the decline in the ATP
concentration. In Fig. 3B, a change in pH from 6.5 to 7.5
corresponds to a change in proton concentration of
0.285 µ; the change in ATP concentration was 200 µ.
Given the low affinity of the inhibitory pH action
(pKa = 5.98, corresponding to a proton concentration of
almost exactly 1 µ) and the slow perfusion rate (time
constant of exchange of ~4 s), it is quite likely that the
receptor deprotonated before ATP could unbind. 
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Figure 9. Zinc concentration–response relations for
H120A, H213A and wild-type P2X2 in the presence of
10 mM ATP
All currents were normalized to the currents induced by ATP in the
absence of zinc, and each point represents the mean ± ... of
5–13 oocytes. The continuous line represents a fit to all data from
H120A and H213A (IC50 = 112 µ, Hill coefficient = 1.38). The
dashed line represents the predicted relation between zinc
concentration and potentiation of wild-type P2X2
(EC50 = 16.5 µ, Hill coefficient = 0.92) based on the assumption
that an inhibitory process identical to that seen in H120A and
H213A also occurs in wild-type, but is partially masked by the
potentiating effect of ATP.
Figure 10. The inhibition of H120A and H213A mutant
receptor currents by high concentrations of zinc (200 mM)
is voltage independent 
A and B, the response of H120A (A) and H213A (B) to 10 µ ATP
followed by 10 µ ATP with 200 µ zinc at two different
potentials. The lengths of the bars above the graphs indicate the
duration of application. C, percentage inhibition of mutant
receptor currents by 200 µ zinc at different potentials.
The H319A mutation must have also caused an additional,
pH-independent decrease in the maximum response, since
the 6-fold decrease in the maximum response of H319A
compared with wild-type P2X2 at pH 7.5 (Table 1) is more
than expected from the inhibitory pH response alone.
Distinguishing whether this pH-independent reduction of
the maximal response was due to a reduction in the
number of functional channels, the single-channel
conductance or the probability of the channel being open
will require single-channel recordings. 
The proton binding site?
A simple model for pH sensing would be that protonation
of a single histidine is necessary and sufficient to account
for pH potentiation. One prediction of this model is that
replacing this histidine with a positively charged residue
should lock the receptor in the potentiated state, which
would be characterized by a greatly left-shifted ATP
concentration–response relation at pH 7.5. This is exactly
what was observed with the H319K mutant. However, this
simple model also predicts that replacing this histidine
with an uncharged residue should lock the receptor in the
unpotentiated state, which would be expected to produce a
rightward shift of the concentration–response relation at
pH 7.5. However, the H319A mutation produced a slight
leftward shift. An even more serious apparent problem
with this model is that both H319A and H319K still display
potentiation as the pH becomes more acidic. Thus H319
cannot be the only pH sensor associated with potentiation
in P2X2. 
The properties of the residual potentiation observed in
H319A and H319K were different in three important ways
from the potentiation shown in wild-type P2X2. First, the
pKa was shifted by nearly a full pH unit, from 6.8 in P2X2 to
7.6 in the H319 mutants. Second, the maximum
potentiation that was achieved in these mutants was far
less than could be achieved in the wild-type. Third, this
potentiation did not effectively occlude zinc potentiation.
Interestingly, treating wild-type P2X2 receptors with the
histidyl-modifying agent DEPC also created receptors that
retained the ability to be potentiated by pH, but showed a
much smaller maximum response (Stoop et al. 1997;
Wildman et al. 1998), suggesting that this inhibitory action
of DEPC may occur by modification of H319. It seems
possible that the residual potentiation observed when
H319 is replaced may be the result of a separate process
that is usually hidden beneath a more efficacious process
that requires H319. If this idea is correct, then there would
actually be three separate pH-dependent processes in
P2X2: a low efficacy potentiation process with a pKa near
7.6, a high efficacy potentiation process with a pKa near 6.8
that requires H319 and an inhibitory process with a pKa
near 6.0. Another possibility is that mutation of H319
indirectly altered pH potentiation. For example, protonation
of H319 might stabilize a closed state of P2X2 through an
interaction dependent upon the chemical structure of the
imidazole side-chain. Since an alanine is a poor substitute
for an imidazole group and a lysine is an even worse
substitute, both H319A and H319K (as well as the reaction
of H319 with DEPC) would favour the open state of P2X2.
This would be expected to decrease the EC50 of the ATP
concentration–response relation and increase the pKa of
pH potentiation as observed. However, this mechanism
does not readily explain why the maximal response
obtainable with pH potentiation was decreased in the
H319A and H319K mutants. 
Regardless of whether the H319 mutations have
completely eliminated one of two types of pH potentiation
or only modified the way a single potentiation process is
expressed, the residual potentiation and the inhibition
apparent in these mutants indicates that there must be
additional amino acids involved in pH sensing. Several
possibilities remain open. First, the other extracellular
histidines may not be sufficient to have a discernable effect
when mutated by themselves, but their role might become
more apparent when H319 is absent. Second, other amino
acids may be involved. Although the pKa of potentiation of
P2X2 receptor currents by pH is outside the range of pKa
values for the side groups of other free amino acids
(aspartate, 3.85; glutamate, 4.25; cysteine, 8.5; tyrosine, 10.05;
lysine, 10.53; arginine, 12.48) (Chang, 1981), it is possible
that the local electrostatic environment may bring the pKa
of one of these amino acids into the range seen for pH
modulation of P2X2 receptors. Third, one must consider
the effects of pH on ATP itself, since the tertiary phosphate
group of ATP titrates with a pKa of 6.95 (Alberty, 1968).
Calculations by three groups (Li et al. 1996; King et al.
1997; Stoop et al. 1997) have shown that the pH-dependent
changes in the species of ATP do not correlate with
changes in receptor properties; however, it is possible that
ATP bound to the receptor may bind protons with a
different affinity than free ATP.
The zinc binding site?
Our finding that H120 and H213 are necessary for zinc
modulation of P2X2 receptors is in keeping with the role of
histidines in zinc modulation of other ion channels (Wang
et al. 1995; Wooltorton et al. 1997; Choi & Lipton, 1999;
Harvey et al. 1999; Paoletti et al. 2000). Interestingly, H120
and H213 are not conserved in rat P2X4, which also
potentiates to zinc: H120 is replaced with a lysine and H213
is replaced by serine. Although both serine and lysine
residues are found in some zinc-binding domains
(Christianson, 1991; Paoletti et al. 2000), we do not know
if mutations at these residues alter zinc potentiation of
P2X4 receptor currents. The lack of identity between
histidines in P2X2 and P2X4 receptors may explain the
smaller zinc potentiation of P2X4 receptor currents
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compared with those of P2X2 as well as the differential
regulation of these subtypes by copper (Xiong et al. 1999;
Acuna-Castillo et al. 2000). A human P2X2 receptor has
recently been cloned and characterized (Lynch et al. 1999).
In human P2X2, H120 is conserved but H213 is replaced by
an arginine; whether human P2X2 receptor currents are
potentiated by zinc is not known. 
As has been eloquently argued, whether a residue
participates in ligand binding or a later step in receptor
gating cannot be dissociated from an analysis of macro-
scopic currents (Colquhoun, 1998). One argument against
a role for these histidines in binding zinc is that DEPC,
which renders histidines incapable of binding zinc, does
not affect zinc potentiation (Wildman et al. 1998). The
lack of an effect of DEPC could be explained if H120 and
H213 alter responsiveness to zinc remotely from the
binding site, since DEPC modification might not alter the
key features of such a remote site. However, the lack of an
effect of DEPC on zinc potentiation could also be
explained if H120 and H213 are part of the zinc binding
site, but the access pathway to this site is too narrow for
DEPC to enter. A direct role for H120 and H213 in zinc
binding is consistent with the well-known role of
histidines in the zinc binding sites of many transcription
factors, enzymes and structural proteins (Christianson,
1991). In addition, mutations at H120 and H213 do not
dramatically alter the response to ATP or protons,
suggesting that these mutations did not dramatically
disrupt receptor gating. In order to participate in the same
zinc binding site, H120 and H213 must be close together in
the three-dimensional protein structure. In most zinc-
binding proteins, zinc complexes with either three or four
residues (Christianson, 1991). Thus, if we assume that H120
and H213 represent bona fide zinc-binding residues, zinc
should bind to one or two additional sites. Besides
additional sites on the receptor, the terminal phosphates of
ATP can also complex with zinc, similar to the binding to
magnesium (Orioli et al. 1980). Thus, zinc might be bound
between H120 and H213 on the receptor and the two
terminal phosphates of ATP. 
Regardless of the molecular mechanism by which the
mutations at H120, H213 and H319 alter zinc or pH
potentiation, the identification of mutant receptors in
which either zinc or pH potentiation is eliminated with
relatively little change in other receptor properties provides
exciting new opportunities. For instance, it focuses
attention on these sites as potential targets of drugs that
selectively block these modulations, but do not alter
normal ATP-activated signalling. The availability of such
agents would allow one to more directly assess the
physiological importance of these modulatory sites than
has so far been possible.
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